Ross Wheatcroft has joined Axol Bioscience as Global Strategic Accounts Manager and will lead the Strategic Account Management team supporting our most important customer base.  Ross’ focus is to drive the Axol strategy and work with key strategic customers to deliver key iPSC projects and products to help them achieve their critical research faster.  Experienced in delivering results and key collaborations, he and his team will work to grow sales for quality human cell culture systems and custom services for disease modelling and drug discovery.  


    Ross has spent 20 years within Diagnostics and Life Sciences both technically and commercially.  He spent 8 years as a Clinical Pathologist developing and validating assays in CRO’s for preclinical toxicology and clinical trials before moving into Commercial Sales.   For the last 12 years during his commercial career he has worked across a number of diagnostic and life science companies delivering technologies and assays to new markets, delivering growth and key partnerships.  


    Outside his work commitments, Ross is a family man who enjoys playing Rugby and travelling. 


    Share this post:

    Axol Bioscience and Censo Biotechnologies Announce Merger

    Introducing Axol's Global Head of Product Management